292 related articles for article (PubMed ID: 22552293)
1. Cancer cell secretion of the DAMP protein HMGB1 supports progression in malignant mesothelioma.
Jube S; Rivera ZS; Bianchi ME; Powers A; Wang E; Pagano I; Pass HI; Gaudino G; Carbone M; Yang H
Cancer Res; 2012 Jul; 72(13):3290-301. PubMed ID: 22552293
[TBL] [Abstract][Full Text] [Related]
2. HMGB1 targeting by ethyl pyruvate suppresses malignant phenotype of human mesothelioma.
Pellegrini L; Xue J; Larson D; Pastorino S; Jube S; Forest KH; Saad-Jube ZS; Napolitano A; Pagano I; Negi VS; Bianchi ME; Morris P; Pass HI; Gaudino G; Carbone M; Yang H
Oncotarget; 2017 Apr; 8(14):22649-22661. PubMed ID: 28186988
[TBL] [Abstract][Full Text] [Related]
3. Asbestos induces mesothelial cell transformation via HMGB1-driven autophagy.
Xue J; Patergnani S; Giorgi C; Suarez J; Goto K; Bononi A; Tanji M; Novelli F; Pastorino S; Xu R; Caroccia N; Dogan AU; Pass HI; Tognon M; Pinton P; Gaudino G; Mak TW; Carbone M; Yang H
Proc Natl Acad Sci U S A; 2020 Oct; 117(41):25543-25552. PubMed ID: 32999071
[TBL] [Abstract][Full Text] [Related]
4. HMGB1 as a Potential Biomarker and Therapeutic Target for Malignant Mesothelioma.
Wang Y; Jiang Z; Yan J; Ying S
Dis Markers; 2019; 2019():4183157. PubMed ID: 30891101
[TBL] [Abstract][Full Text] [Related]
5. Aspirin delays mesothelioma growth by inhibiting HMGB1-mediated tumor progression.
Yang H; Pellegrini L; Napolitano A; Giorgi C; Jube S; Preti A; Jennings CJ; De Marchis F; Flores EG; Larson D; Pagano I; Tanji M; Powers A; Kanodia S; Gaudino G; Pastorino S; Pass HI; Pinton P; Bianchi ME; Carbone M
Cell Death Dis; 2015 Jun; 6(6):e1786. PubMed ID: 26068794
[TBL] [Abstract][Full Text] [Related]
6. HMGB1 released by mesothelial cells drives the development of asbestos-induced mesothelioma.
Suarez JS; Novelli F; Goto K; Ehara M; Steele M; Kim JH; Zolondick AA; Xue J; Xu R; Saito M; Pastorino S; Minaai M; Takanishi Y; Emi M; Pagano I; Wakeham A; Berger T; Pass HI; Gaudino G; Mak TW; Carbone M; Yang H
Proc Natl Acad Sci U S A; 2023 Sep; 120(39):e2307999120. PubMed ID: 37729199
[TBL] [Abstract][Full Text] [Related]
7. Asbestos-induced chronic inflammation in malignant pleural mesothelioma and related therapeutic approaches-a narrative review.
Zolondick AA; Gaudino G; Xue J; Pass HI; Carbone M; Yang H
Precis Cancer Med; 2021 Sep; 4():. PubMed ID: 35098108
[TBL] [Abstract][Full Text] [Related]
8. Molecular pathways: targeting mechanisms of asbestos and erionite carcinogenesis in mesothelioma.
Carbone M; Yang H
Clin Cancer Res; 2012 Feb; 18(3):598-604. PubMed ID: 22065079
[TBL] [Abstract][Full Text] [Related]
9. Expression analysis of HMGB1 in histological samples of malignant pleural mesothelioma.
Rrapaj E; Trisolini E; Bertero L; Salvo M; Indellicato R; Andorno S; Garcia-Manteiga JM; Rena O; Boldorini RL
Histopathology; 2018 May; 72(6):1039-1050. PubMed ID: 29356044
[TBL] [Abstract][Full Text] [Related]
10. Serum HMGB1 as a diagnostic marker for malignant peritoneal mesothelioma.
Tabata C; Kanemura S; Tabata R; Masachika E; Shibata E; Otsuki T; Nishizaki T; Nakano T
J Clin Gastroenterol; 2013 Sep; 47(8):684-8. PubMed ID: 23685846
[TBL] [Abstract][Full Text] [Related]
11. Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammation.
Yang H; Rivera Z; Jube S; Nasu M; Bertino P; Goparaju C; Franzoso G; Lotze MT; Krausz T; Pass HI; Bianchi ME; Carbone M
Proc Natl Acad Sci U S A; 2010 Jul; 107(28):12611-6. PubMed ID: 20616036
[TBL] [Abstract][Full Text] [Related]
12. Malignant mesothelioma growth inhibition by agents that target the VEGF and VEGF-C autocrine loops.
Masood R; Kundra A; Zhu S; Xia G; Scalia P; Smith DL; Gill PS
Int J Cancer; 2003 May; 104(5):603-10. PubMed ID: 12594815
[TBL] [Abstract][Full Text] [Related]
13. Temsirolimus inhibits malignant pleural mesothelioma growth in vitro and in vivo: synergism with chemotherapy.
Hoda MA; Mohamed A; Ghanim B; Filipits M; Hegedus B; Tamura M; Berta J; Kubista B; Dome B; Grusch M; Setinek U; Micksche M; Klepetko W; Berger W
J Thorac Oncol; 2011 May; 6(5):852-63. PubMed ID: 21358348
[TBL] [Abstract][Full Text] [Related]
14. A proteomics-based approach identifies secreted protein acidic and rich in cysteine as a prognostic biomarker in malignant pleural mesothelioma.
Kao SC; Kirschner MB; Cooper WA; Tran T; Burgers S; Wright C; Korse T; van den Broek D; Edelman J; Vallely M; McCaughan B; Pavlakis N; Clarke S; Molloy MP; van Zandwijk N; Reid G
Br J Cancer; 2016 Mar; 114(5):524-31. PubMed ID: 26889976
[TBL] [Abstract][Full Text] [Related]
15. CSPG4 as a target of antibody-based immunotherapy for malignant mesothelioma.
Rivera Z; Ferrone S; Wang X; Jube S; Yang H; Pass HI; Kanodia S; Gaudino G; Carbone M
Clin Cancer Res; 2012 Oct; 18(19):5352-63. PubMed ID: 22893632
[TBL] [Abstract][Full Text] [Related]
16. The inhibition of FGF receptor 1 activity mediates sorafenib antiproliferative effects in human malignant pleural mesothelioma tumor-initiating cells.
Pattarozzi A; Carra E; Favoni RE; Würth R; Marubbi D; Filiberti RA; Mutti L; Florio T; Barbieri F; Daga A
Stem Cell Res Ther; 2017 May; 8(1):119. PubMed ID: 28545562
[TBL] [Abstract][Full Text] [Related]
17. Calretinin is essential for mesothelioma cell growth/survival in vitro: a potential new target for malignant mesothelioma therapy?
Blum W; Schwaller B
Int J Cancer; 2013 Nov; 133(9):2077-88. PubMed ID: 23595591
[TBL] [Abstract][Full Text] [Related]
18. Functional Analysis of the Adrenomedullin Pathway in Malignant Pleural Mesothelioma.
Greillier L; Tounsi A; Berenguer-Daizé C; Dussault N; Delfino C; Benyahia Z; Cayol M; Mabrouk K; Garcia S; Martin PM; Barlesi F; Ouafik L
J Thorac Oncol; 2016 Jan; 11(1):94-107. PubMed ID: 26762744
[TBL] [Abstract][Full Text] [Related]
19. Humanized anti-CD26 monoclonal antibody as a treatment for malignant mesothelioma tumors.
Inamoto T; Yamada T; Ohnuma K; Kina S; Takahashi N; Yamochi T; Inamoto S; Katsuoka Y; Hosono O; Tanaka H; Dang NH; Morimoto C
Clin Cancer Res; 2007 Jul; 13(14):4191-200. PubMed ID: 17634548
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of fibulin-3 in tumor tissue predicts poor survival of malignant mesothelioma patients from hand-spinning asbestos exposed area in eastern China.
Jiang Z; Shen W; Ying S; Gao Z; He X; Chen R; Xia H; Guo X; Fang Y; Zhang Y; Miao J; Zhou J; Zhang X; Chen J; Lou J
Sci Rep; 2020 Nov; 10(1):20373. PubMed ID: 33230247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
